ロード中...
RAS-MAPK signaling influences the efficacy of ALK-targeting agents in lung cancer
ALK (anaplastic lymphoma kinase) inhibitors are approved in for ALK gene rearrangement positive (ALK+) lung cancer, but resistance remains a challenge. We discovered that RAS-RAF-MEK-ERK signaling controls the ALK inhibitor response in ALK+ lung cancer and is critical for ALK inhibitor resistance. U...
保存先:
| 出版年: | Mol Cell Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905399/ https://ncbi.nlm.nih.gov/pubmed/27308613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1091061 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|